Imaging for early stage breast cancer

TARGIT. Pre- vs Post-pathology

3451 patients recruited between 2000 and 2012

• Pre-pathology stratum (n=2298) : LR: TARGIT 2.1% vs EBRT 1.1% (p=0.31)

PgR+ predictor of outcome

• Post-pathology stratum (n=1153) : LR: TARGIT 5.4% vs EBRT 1.7% (p=0.069)

Vaidya JS et al, Health Tecnol Assess 2016